Strong product pipeline are anticipated to impact the industrial growth over the forecast period of 2019–2030. The novel products are designed to help in development of DNA targeting, with improved flexibility, specificity of nuclease, and the ease of Adeno-Associate Virus (AAV) packaging for delivery. Moreover, utilization of the technique through a number of methods such as disruption of viral DNA, correction in the toxic mutations, or the addition of therapeutic transgenes is projected to boost the adoption.
The Genome Editing/Genome Engineering Market is segmented on the basis of Technology, Applications, End Users and region.
Major Technology of Genome Editing/Genome Engineering Market covered are:
- CRISPR
- TALEN
- ZFN
Major Applications of Genome Editing/Genome Engineering Market covered are:
- Cell Line Engineering
- Genetic Engineering
Major End Users of Genome Editing/Genome Engineering Market covered are:
- Research Centers
- Pharmaceutical & Biotechnology Companies
- CROs
Application of the technology for cell line genetic editing or engineering in the form of gene therapy and stem cell therapy accounted for the considerable share and is estimated to register lucrative growth. Furthermore, use of the genome editing technology for the development of novel molecules which can be targeted for treating various diseases such as infectious diseases and hematological malignancies is likely to drive the adoption of the technology in the coming years.
Toxicity owing to off-target effects of the nucleases is a major safety concern for the market restraining the market growth. In addition, the IP disputes relating to CRISPR technology between the industry players is estimated to restrain growth in near future.
No comments:
Post a Comment